Smith–Magenis syndrome (SMS; OMIM #182290) and Potocki–Lupski syndrome (PTLS; OMIM #610883) are rare neurodevelopmental disorders that underscore the critical role of dosage-sensitivity in the RAI1 gene in determining distinct clinical outcomes [2]. Here, RAI1 is linked to neurodevelopmental disorder.